You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 11,034,660

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,034,660 protect, and when does it expire?

Patent 11,034,660 protects XPOVIO and is included in one NDA.

This patent has ninety-five patent family members in thirty-six countries.

Summary for Patent: 11,034,660

Title:	Hydrazide containing nuclear transport modulators and uses thereof
Abstract:	The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
Inventor(s):	Sandanayaka; Vincent P. (Northboro, MA), Shacham; Sharon (Newton, MA), McCauley; Dilara (Arlington, MA), Shechter; Sharon (Andover, MA)
Assignee:	Karyopharm Therapeutics Inc. (Newton, MA)
Application Number:	16/696,702
Patent Claim Types: see list of patent claims	Use; Dosage form;
Patent landscape, scope, and claims:	Analyzing the Scope and Claims of United States Patent 11,034,660: A Comprehensive Guide Introduction Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of analyzing the scope and claims of a specific patent, using United States Patent 11,034,660 as an example. We will explore the tools, resources, and methodologies available for this analysis. Understanding Patent Scope and Claims Patent scope and claims define the boundaries of what is protected by a patent. The claims section is the most critical part of a patent, as it outlines the specific elements that must be present for an invention to be considered infringing[3]. Locating the Patent To begin analyzing a patent, you need to locate the patent document. The United States Patent and Trademark Office (USPTO) provides several resources for this: USPTO Website: You can search for patents directly on the USPTO website. Full text and images of patents from 1976 to the present are available, along with images and classification numbers for patents from 1790 to 1975[4]. Global Dossier: This service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices[1]. Analyzing the Claims The claims section of a patent is where the legal boundaries of the invention are defined. Claim Structure: Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3]. Claim Language: The language used in claims is precise and technical. Understanding the terminology and the relationships between claims is essential for determining the scope of the patent. Tools for Patent Analysis Several tools and resources are available to help analyze patents: Patent Claims Research Dataset: This dataset, provided by the USPTO, contains detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. It includes claim-level statistics and document-level statistics, which can help in understanding the scope and complexity of patent claims[3]. Common Citation Document (CCD): The CCD consolidates prior art cited by all participating offices for the family members of a patent application, providing a single point of access to up-to-date citation data[1]. Patent Family and Global Dossier Understanding the patent family is crucial for a comprehensive analysis: Patent Family: The Global Dossier service allows users to view all related applications filed at participating IP Offices, along with the dossier, classification, and citation data for these applications[1]. Office Action Indicators: This feature helps identify applications that contain office actions, which can provide insights into the examination process and potential challenges to the patent's validity[1]. Historical Context and Prior Art Analyzing the historical context and prior art is essential for understanding the novelty and non-obviousness of the invention: Historical Patents: Resources like the NYPL Libguides provide access to historical U.S. patents, which can be used to determine whether an idea has been previously patented[4]. Digest of Patents: Annual reports from the Commissioner of Patents and other historical documents can provide valuable context on the development of similar inventions over time[4]. Legal and Policy Considerations Legal and policy considerations play a significant role in patent analysis: Small Claims Patent Court: Studies and discussions around the establishment of a small claims patent court highlight the need for efficient and cost-effective dispute resolution mechanisms. This can impact how patents are enforced and defended[5]. Practical Steps for Analysis Step 1: Locate the Patent Search for the patent on the USPTO website or through other patent search databases like Google Patents or the European Patent Office's Espacenet. Step 2: Read the Claims Carefully read the claims section to understand the specific elements of the invention that are protected. Step 3: Analyze the Patent Family Use the Global Dossier to view related applications and understand the broader context of the patent. Step 4: Review Prior Art Use resources like the CCD and historical patent databases to identify prior art that may affect the patent's validity. Step 5: Consider Legal and Policy Implications Understand the legal and policy environment in which the patent exists, including potential changes like the establishment of a small claims patent court. Example Analysis: United States Patent 11,034,660 To illustrate this process, let's consider a hypothetical analysis of United States Patent 11,034,660: Locate the Patent: Search for the patent on the USPTO website. Read the Claims: Identify the independent and dependent claims and understand their relationships. Analyze the Patent Family: Use the Global Dossier to view related applications and understand the broader context. Review Prior Art: Use the CCD and historical patent databases to identify relevant prior art. Consider Legal and Policy Implications: Review any ongoing legal or policy discussions that may impact the patent. Key Takeaways Precision in Claims: The claims section is the heart of a patent, and understanding its language and structure is crucial. Global Context: Analyzing the patent family and prior art globally helps in understanding the invention's novelty and non-obviousness. Legal Considerations: Keeping abreast of legal and policy developments can significantly impact how a patent is enforced and defended. Tools and Resources: Utilize datasets, global dossier services, and historical patent resources to conduct a thorough analysis. FAQs Q: How do I locate a specific patent on the USPTO website? A: You can search for patents directly on the USPTO website using the patent number, title, or other relevant keywords. Q: What is the importance of the claims section in a patent? A: The claims section defines the legal boundaries of the invention and is the most critical part of a patent. Q: How does the Global Dossier help in patent analysis? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to view the patent family and related documentation. Q: What is the Common Citation Document (CCD), and how is it useful? A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, providing a single point of access to up-to-date citation data. Q: Why is understanding prior art important in patent analysis? A: Understanding prior art helps in determining the novelty and non-obviousness of the invention, which are key criteria for patentability. Sources USPTO - Search for patents: https://www.uspto.gov/patents/search USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 11,034,660

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH DEXAMETHASONE TO TREAT RELAPSED OR REFRACTORY MULTIPLE MYELOMA (REFRACTORY TO AT LEAST AN ANTI-CD38 MAB, 2 PROTEASOME INHIBITORS AND 2 IMMUNOMODULATORY AGENTS) IN ADULTS WHO RECEIVED AT LEAST 4 PRIOR THERAPIES	⤷ Subscribe
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY	⤷ Subscribe
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-002	Apr 15, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH DEXAMETHASONE TO TREAT RELAPSED OR REFRACTORY MULTIPLE MYELOMA (REFRACTORY TO AT LEAST AN ANTI-CD38 MAB, 2 PROTEASOME INHIBITORS AND 2 IMMUNOMODULATORY AGENTS) IN ADULTS WHO RECEIVED AT LEAST 4 PRIOR THERAPIES	⤷ Subscribe
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-002	Apr 15, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY	⤷ Subscribe
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-003	Apr 15, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH DEXAMETHASONE TO TREAT RELAPSED OR REFRACTORY MULTIPLE MYELOMA (REFRACTORY TO AT LEAST AN ANTI-CD38 MAB, 2 PROTEASOME INHIBITORS AND 2 IMMUNOMODULATORY AGENTS) IN ADULTS WHO RECEIVED AT LEAST 4 PRIOR THERAPIES	⤷ Subscribe
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-003	Apr 15, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				XPOVIO IS INDICATED IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,034,660

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2736887	⤷ Subscribe	301119	Netherlands	⤷ Subscribe
European Patent Office	2736887	⤷ Subscribe	PA2021007	Lithuania	⤷ Subscribe
European Patent Office	2736887	⤷ Subscribe	CA 2021 00031	Denmark	⤷ Subscribe
European Patent Office	2736887	⤷ Subscribe	LUC00219	Luxembourg	⤷ Subscribe
European Patent Office	2736887	⤷ Subscribe	2021C/532	Belgium	⤷ Subscribe
European Patent Office	2736887	⤷ Subscribe	122021000055	Germany	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.